It doesn’t. That’s what I mean when I tell you the bottleneck is somewhere else. Obviously everyone claims that they do this with new technology X, but empirically, it isn’t helpful.

Re-ranking pre-clinical leads is the scientific equivalent of that old saying about opinions.